Mini Review
Published on 08 Jun 2022
Digital Therapeutics in Perspective: From Regulatory Challenges to Post-Marketing Surveillance
in Substance-Based Medical Devices
Frontiers in Drug Safety and Regulation
doi 10.3389/fdsfr.2022.900946
- 7,900 views
- 19 citations